The caregiver role in thromboprophylaxis management in atrial fibrillation: A literature review

European Journal of Cardiovascular Nursing

Volumn 14, Issue 2, 2015, Pages 98-107

  Ferguson, Caleb ^a   Inglis, Sally C ^a   Newton, Phillip J ^a   Middleton, Sandy ^b   Macdonald, Peter S ^c   Davidson, Patricia M ^a,d  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; caregiver; caregiver education; caregiver role; family support; stroke prevention; thromboprophylaxis

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; CAREGIVER; CAREGIVER BURDEN; CAREGIVER SUPPORT; CLINICAL PRACTICE; CLINICAL RESEARCH; DECISION MAKING; EDUCATIONAL STATUS; FAMILY COUNSELING; HEART ATRIUM FIBRILLATION; HUMAN; PATIENT ADVOCACY; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; THROMBOSIS; THROMBOSIS PREVENTION; ATRIAL FIBRILLATION; COMPLICATION; MEDICATION COMPLIANCE; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CAREGIVERS; HUMANS; MEDICATION ADHERENCE; STROKE;

EID: 84925434575     PISSN: 14745151     EISSN: 18731953     Source Type: Journal    
DOI: 10.1177/1474515114547647     Document Type: Review

References (69)

1. Naccarelli G, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009 ; 104: 1534-1539
2. Wong CX, Brooks AG, Leong DP, et al. The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: A 15 year study of all hospitalisations in Australia. Arch Intern Med. 2012 ; 172: 739-740
3. Ball J, Carrington M, McMurray JJV, et al. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013 ; 167: 1807-24
4. Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity, and risk of stroke: The Framingham Study. JAMA. 1981 ; 245: 1225-1229
5. Gattellari M, Goumas C, Aitken R, et al. Outcomes for patients with ischaemic stroke and atrial fibrillation: The PRIMS Study (A Program of Research Informing Stroke Management). Cerebrovasc Dis. 2011 ; 32: 370-382
6. Khan M, Ahmed B, Ahmed M, et al. Functional, cognitive and psychological outcomes, and recurrent vascular events in Pakistani stroke survivors: A cross sectional study. BMC Res Notes. 2012 ; 5: 89:
7. Kang X, Li Z, Nolan M.. Informal caregivers' experiences of caring for patients with chronic heart failure. J Cardiovasc Nurs. 2011 ; 26: 386-394
8. Funk L, Chappell N, Liu G.. Associations between filial responsibility and caregiver well-being: Are there differences by cultural group?. Res Aging. 2013 ; 35: 78-95
9. The National Alliance for Caregiving in collaboration with AARP. Caregiving in the US. http://www.caregiving.org/data/Caregiving-in-the-US-2009-full-report.pdf2009:1-79 (2009, accessed )
10. Evercare by United Healthcare. The Evercare Survey of the economic downturn and its impact on family caregiving: Report of findings. http://www.caregiving.org/data/EVC-Caregivers-Economy-Report%20FINAL-4-28-09.pdf (2009, accessed 1st Nov 2012).
11. Davidson PM, Abernethy AP, Newton PJ, et al. The caregiving perspective in heart failure: A population based study. BMC Health Serv Res. 2013 ; 13: 342
12. Grey M, Knafl K, McCorkle R.. A framework for the study of self- and family management of chronic conditions. Nurs Outlook. 2006 ; 54: 278-286
13. Lip GYH. Implications of the CHA2DS2-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillation. Am J Med. 2011 ; 124: 111-114
14. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation. 2006 ; 114: e257 - e354
15. Guidelines for the management of atrial fibrillation. Eur Heart J. 2010 ; 31: 2369-2429
16. Atrial fibrillation. The management of atrial fibrillation. National Institute for Clinical Excellence ; 2006, UK:
17. Singer D, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 ; 126: 429S
18. Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 ; 123: 104-123
19. Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Eur Heart J. 2012 ; 33: 2719-2747
20. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists. Chest. 2008 ; 133: 160S - 198S
21. Ferguson C, Inglis SC, Newton PJ, et al. Atrial fibrillation: Stroke prevention in focus. Aust Crit Care. 2014 ; 27: 92-98
22. Adherence to long term therapies: Evidence for action. Geneva, Switzerland: World Health Organization ; 2003:
23. Haynes R, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 ; 2: 1-158
24. O'Connor PJ. Improving medication adherence: Challenges for physicians, payers and policy makers. Arch Intern Med. 2006 ; 166: 1802-1804
25. Mahtani K, Heneghan C, Glasziou P, et al. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011 ; 9: 1-62
26. Reynolds MR, Shah J, Essebag V, et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 ; 97: 538-543
27. Fang MC, Go AS, Chang Y, et al. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 ; 3: 624-631
28. Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: Results of the ONTARGET and TRANSCEND studies. Can Med Assoc J. 2012 ; 184: E329-36
29. Chen S-Y, Vanderpoel J, Mody S, et al. Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment. Am J Geriatr Pharmacother. 2012 ; 10: 273-283
30. Appelboam R, Thomas EO.. Warfarin and intracranial haemorrhage. Blood Rev. 2009 ; 23: 1-9
31. Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicentre study. Stroke. 2001 ; 32: 2567-2574
32. Lackie CL, Garbarino KA, Pruetz JA.. Warfarin therapy for atrial fibrillation in the elderly. Ann Pharmacother. 2002 ; 36: 200-204
33. Coleman CI, Coleman SM, Vanderpoel J, et al. Factors associated with 'caregiver burden' for atrial fibrillation patients. Int J Clin Pract. 2012 ; 66: 984-990
34. Ho P, Bryson C, Rumsfeld J.. Medication adherence. Circulation. 2009 ; 119: 3028-3035
35. Osterberg L, Blaschke T.. Adherence to medication. N Engl J Med. 2005 ; 353: 487-497
36. Brown T, Siu K, Walker D, et al. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Manag Care Pharm. 2012 ; 18: 351-362
37. Hendriks JML, deWit R, Crijns HJGM, et al. Nurse-led care vs usual care for patients with atrial fibrillation. European Heart Journal. 2012 ; 33: 2692-2699
38. Berti D, Hendriks JML, Brandes A, et al. A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. Eur Heart J. 2013 ; 34: 2725-2730
39. Ferguson C, Inglis S, Newton P, et al. Atrial fibrillation and thromboprophylaxis in heart failure: The need for patient-centered approaches to address adherence. Vasc Health Risk Manag. 2013 ; 9: 3-11.
40. Tang E, Lai C, Lee K, et al. Relationship between patient's warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003 ; 37: 34-39
41. Bockwoldt D.. Antithrombosis management in community-dwelling elderly: Improving safety. Geriatr Nurs. 2010 ; 31: 28-36
42. Bajorek BV, Ogle SJ, Duguid MJ, et al. Management of warfarin in atrial fibrillation: Views of health professionals, older patients and their carers. Med J Aust. 2007 ; 186: 175-180
43. Bereznicki LR, Peterson GM, Jackson SL, et al. The risks of warfarin use in the elderly. Expert Opin Drug Saf. 2006 ; 5: 417-431
44. Dolor RJ, Ruybalid RL, Uyeda L, et al. An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: Pre-randomization results of VA Cooperative Study #481 - The Home INR Study (THINRS). J Thromb Thrombolysis. 2010 ; 30: 263-75
45. Horstkotte D, Piper C.. Improvement of oral anticoagulation therapy by INR self-management. J Heart Valve Dis. 2004 ; 13: 335-338
46. Hylek E.. Oral anticoagulants: Pharmacological issues for use in the elderly. Clin Geriatr Med. 2001 ; 17: 1-13
47. Lip GYH, Tse H. Management of atrial fibrillation. Lancet. 2007 ; 370: 604-618
48. Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother. 2004 ; 2: 36-43
49. Rose AJ, Hylek EM, Ozonoff A, et al. Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost. 2010 ; 8: 2182-2191
50. Patterson S, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people (Review). Cochrane Database Syst Rev. 2012 ; 5: 1-81
51. Lip GYH. The balance between stroke prevention and bleeding risk in atrial fibrillation: A delicate balance revisited. Stroke. 2008 ; 39: 1406-1409
52. Devereaux PJ, Fahey T, Anderson DR, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study commentary: Varied preferences reflect the reality of clinical practice. BMJ. 2001 1218 ; 323:
53. Forman DE, Rich MW, Alexander KP, et al. Cardiac care for older adults: Time for a new paradigm. J Am Coll Cardiol. 2011 ; 57: 1801-1810
54. Abdelhafiz AH.. A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation. Clin Ther. 2001 ; 23: 1628-1636
55. Johnston JA, Cluxton Jr RJ, Heaton PC, et al. Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med. 2003 ; 163: 1705-1710
56. Dudley N.. Importance of risk communication and decision making in cardiovascular conditions in older patients: A discussion paper. Qual Health Care. 2001 ; 10: i19 - i22
57. Milte CM, Ratcliffe J, Davies O, et al. Family meetings for older adults in intermediate care settings: The impact of patient cognitive impairment and other characteristics on shared decision making. Health Expect. 2013 ;:
58. Ismail H, Lewin RJ.. The role of a new arrhythmia specialist nurse in providing support to patients and caregivers. Eur J Cardiovasc Nurs. 2013 ; 12: 177-183
59. McCabe PJ, Schumacher K, Barnason SA.. Living with atrial fibrillation: A qualitative study. J Cardiovasc Nurs. 2011 ; 26: 336-344
60. Ogilvie IM, Newton N, Welner SA, et al. Underuse of oral anticoagulants in atrial fibrillation: A systematic review. Am J Med. 2010 ; 123: 638-645
61. Turner H, Catania J. Informal Caregiving to Persons with AIDS in the United States: Caregiver Burden Among Central Cities Residents Eighteen to Forty-Nine Years Old. Am J Community Psychol. 1997 ; 25: 35-59
62. Schulz R, Beach SR.. Caregiving as a risk factor for mortality: The caregiver health effects study. JAMA. 1999 ; 282: 23
63. James M.. An analysis of the use of a point-of-care system for international normalized ratio testing in remote areas of Canada: A literature review. Point Care. 2008 ; 7: 34-37
64. Berg AM.. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 ; 154: 570
65. Perissinotto CM, Cenzer IS, Covinsky KE.. Loneliness in older persons. Arch Intern Med. 2012 ; 172: 1078-1083
66. Udell JA, Steg PG, Scirica BM, et al. Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. Arch Intern Med. 2012 ; 172: 1086-1095
67. Perera V, Bajorek BV, Matthews S, et al. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing. 2009 ; 38: 156-162
68. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007 ; 93: 606-612
69. Smit MD, Moes ML, Maass AH, et al. The importance of whether atrial fibrillation or heart failure develops first. Eur J Heart Fail. 2012 ; 14: 1030-40